Concepedia

Author

Bernd Püllmann

Roche (Switzerland)

Also Known As

Bernd Püllmann

7

Publications

170

Citations

6

H-Index

26

Concepts

All Affiliations

Roche (Switzerland)
BP

About

Bernd Püllmann is an author at Roche (Switzerland) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

114

2

Biochemistry

4

4

114

3

Natural Sciences

3

3

91

4

Engineering

1

1

40

5

Chemical Engineering

1

1

40

Bernd Püllmann

×

6

Publications

170

Citations

6

H-Index

YearCitations

Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases

Matthias Nettekoven, Jean‐Michel Adam, Stefanie Bendels,

ChemMedChem

2015

56

Evaluation of a flow-photochemistry platform for the synthesis of compact modules

Matthias Nettekoven, Bernd Püllmann, Rainer E. Martin,

Tetrahedron Letters

2012

40

Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?

Wolfgang Guba, Matthias Nettekoven, Bernd Püllmann,

Bioorganic & Medicinal Chemistry Letters

2004

23

Synthetic Access to 2-Amido-5-aryl-8-methoxy-triazolopyridineand 2-Amido-5-morpholino-8-methoxy-triazolopyridine Derivativesas Potential Inhibitors of the Adenosine Receptor Subtypes

Matthias Nettekoven, Bernd Püllmann, Sébastien Schmitt

Synthesis

2003

22

Parallel iterative solution-phase synthesis of 5-amino-1-aryl-[1,2,4]triazolo[1,5-a]pyridine-7-carboxylic acid amide derivatives

Bernd Brodbeck, Bernd Püllmann, Sébastien Schmitt,

Tetrahedron Letters

2003

16

Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening

Matthias Nettekoven, Jürgen Fingerle, Uwe Grether,

Bioorganic & Medicinal Chemistry Letters

2013

13

Page 1